Search research articles
Contact Us
Filters
Showing results (11-20 of 78) with videos related to
Page
of 8
Sort By:
Antimicrobial Agents and Chemotherapy
|
November 3, 2020
Improbable Results of Urine Isolate Antimicrobial Susceptibility Testing
Paul H Edelstein, Romney M Humphries
Journal of Clinical Microbiology
|
December 20, 2014
Reply to "use of alternative reference standards and exempted species to evaluate the performance of the Vitek 2 GP67 cefoxitin/oxacillin screen for coagulase-negative staphylococci"
Kristen N Johnson, Paul H Edelstein
Vaccine
|
July 19, 2011
Cell mediated immunity in Legionnaires' disease
Paul S Hoffman, Paul H Edelstein
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 11, 2009
Legionella pneumophila goes clonal--Paris and Lorraine strain-specific risk factors
Paul H Edelstein, Joshua P Metlay
Journal of Clinical Microbiology
|
March 5, 2010
Comparison of the plating efficiencies and shelf lives of three different commercial buffered charcoal yeast extract media supplemented with alpha-ketoglutaric acid
Paul H Edelstein, Martha A C Edelstein
BMJ (Clinical Research Ed.)
|
October 26, 2019
Is <i>Mycobacterium tuberculosis</i> infection life long?
Marcel A Behr, Paul H Edelstein, Lalita Ramakrishnan
Journal of Clinical Microbiology
|
October 3, 2014
Development and optimization of a real-time PCR assay for detection of herpes simplex and varicella-zoster viruses in skin and mucosal lesions by use of the BD Max open system
Ana María Cárdenas, Paul H Edelstein, Kevin Alby
Journal of Clinical Microbiology
|
January 16, 2009
Specificity of ertapenem susceptibility screening for detection of Klebsiella pneumoniae carbapenemases
Shannon E McGettigan, Kathleen Andreacchio, Paul H Edelstein
BMJ (Clinical Research Ed.)
|
August 25, 2018
Revisiting the timetable of tuberculosis
Marcel A Behr, Paul H Edelstein, Lalita Ramakrishnan
Nature Microbiology
|
April 26, 2024
Rethinking the burden of latent tuberculosis to reprioritize research
Marcel A Behr, Paul H Edelstein, Lalita Ramakrishnan
Page
of 8
Search research articles
Search
Showing results (11-20 of 78) with videos related to
Sort By:
Page
of 8
Antimicrobial Agents and Chemotherapy
|
November 3, 2020
Improbable Results of Urine Isolate Antimicrobial Susceptibility Testing
Paul H Edelstein, Romney M Humphries
Journal of Clinical Microbiology
|
December 20, 2014
Reply to "use of alternative reference standards and exempted species to evaluate the performance of the Vitek 2 GP67 cefoxitin/oxacillin screen for coagulase-negative staphylococci"
Kristen N Johnson, Paul H Edelstein
Vaccine
|
July 19, 2011
Cell mediated immunity in Legionnaires' disease
Paul S Hoffman, Paul H Edelstein
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 11, 2009
Legionella pneumophila goes clonal--Paris and Lorraine strain-specific risk factors
Paul H Edelstein, Joshua P Metlay
Journal of Clinical Microbiology
|
March 5, 2010
Comparison of the plating efficiencies and shelf lives of three different commercial buffered charcoal yeast extract media supplemented with alpha-ketoglutaric acid
Paul H Edelstein, Martha A C Edelstein
BMJ (Clinical Research Ed.)
|
October 26, 2019
Is <i>Mycobacterium tuberculosis</i> infection life long?
Marcel A Behr, Paul H Edelstein, Lalita Ramakrishnan
Journal of Clinical Microbiology
|
October 3, 2014
Development and optimization of a real-time PCR assay for detection of herpes simplex and varicella-zoster viruses in skin and mucosal lesions by use of the BD Max open system
Ana María Cárdenas, Paul H Edelstein, Kevin Alby
Journal of Clinical Microbiology
|
January 16, 2009
Specificity of ertapenem susceptibility screening for detection of Klebsiella pneumoniae carbapenemases
Shannon E McGettigan, Kathleen Andreacchio, Paul H Edelstein
BMJ (Clinical Research Ed.)
|
August 25, 2018
Revisiting the timetable of tuberculosis
Marcel A Behr, Paul H Edelstein, Lalita Ramakrishnan
Nature Microbiology
|
April 26, 2024
Rethinking the burden of latent tuberculosis to reprioritize research
Marcel A Behr, Paul H Edelstein, Lalita Ramakrishnan
Page
of 8